Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma

American Journal of Dermatopathology

Volumn 27, Issue 4, 2005, Pages 279-285

  Uribe, Pablo ^a   Wistuba, Ignacio I ^a,b   Solar, Antonieta ^a   Balestrini, Claudia ^a   Perez Cotapos, Maria Luisa ^a   Gonzalez, Sergio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Childhood melanoma; Cutaneous melanoma; Loss of heterozygosity; Microsatellite instability; Pediatric melanoma

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 2P; CHROMOSOME 2Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA EXTRACTION; DNA REPAIR; FEMALE; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; MELANOMA; MICROSATELLITE INSTABILITY; NEVUS; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 24144441243     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000171599.40562.7c     Document Type: Article

References (48)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Williams ML, Pennella R. Melanoma, melanocytic nevi, and other melanoma risk factors in children. J Pediatr. 1994;124:833-845.
3. Boddie AW Jr, Smith JL Jr, McBride CM. Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and end results. South Med J. 1978;71:1074-1078.
4. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med. 1995;332:656-662.
5. Trozak DJ, Rowland WD, Hu F. Metastatic malignant melanoma in prepubertal children. Pediatrics. 1975;55:191-204.
6. Sander B, Karlsson P, Rosdahl I, et al. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases. Int J Cancer. 1999;80:646-651.
7. Pratt CB, Palmer MK, Thatcher N, et al. Malignant melanoma in children and adolescents. Cancer. 1981;47:392-397.
8. Avruch J, Khokhlatchev A, Kyriakis JM, et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res. 2001;56:127-155.
9. Temple WJ, Mulloy RH, Alexander F, et al. Childhood melanoma. J Pediatr Surg. 1991;26:135-137.
10. Reintgen DS, Vollmer R, Seigler HF. Juvenile malignant melanoma. Surg Gynecol Obstet. 1989;168:249-253.
11. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
12. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med. 2002;347:1593-1603.
13. Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol. 1996;122:135-140.
14. Healy E, Belgaid CE, Takata M, et al. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res. 1996;56:589-593.
15. Real LM, Jimenez P, Canton J, et al. In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-1 allele. Int J Cancer. 1998;75:317-323.
16. Peris K, Keller G, Chimenti S, et al. Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol. 1995;105:625-628.
17. Fujiwara Y, Hoon DS. Microsatellite analysis of melanoma lesions using (CA)13 oligonucleotides as an internal probe. Int J Oncol. 2000;17:783-787.
18. Robertson GP, Goldberg EK, Lugo TG, et al. Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23. Oncogene. 1999;18:3173-3180.
19. Tomlinson IP, Beck NE, Bodmer WF. Allele loss on chromosome ligand microsatellite instability in malignant melanoma. Eur J Cancer. 1996; 32A:1797-1802.
20. Palmieri G, Ascierto PA, Cossu A, et al. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi. dysplastic naevi, and primary melanomas and their metastases. Melanoma Res. 2003;13:167-170.
21. Hussein MR, Sun M, Roggero E, et al. Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas. Mol Carcinog. 2002;34:35-44.
22. Richetta A, Ottini L, Falchetti M, et al. Instability at sequence repeats in melanocytic tumours. Melanoma Res. 2001;11:283-289.
23. Hussein MR, Roggero E, Sudilovsky EC, et al. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas. Am J Dermatopathol 2001;23:308-314.
24. Birindelli S, Tragni G, Bartoli C, et al. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma. Int J Cancer. 2000; 86:255-261.
25. Indsto JO, Cachia AR, Kefford RF, et al. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi. Clin Cancer Res. 2001;7:4054-4059.
26. Rubben A, Bogdan I, Grussendorf-Conen EI, et al. Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. Recent Results Cancer Res. 2002;160:100-110.
27. Richetta A, Ottini L, Falchetti M, et al. Instability at sequence repeats in melanocytic tumours. Melanoma Res. 2001;11:283-289.
28. Wistuba II, Berry J, Behrens C, et al. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin Cancer Res. 2000; 6:2604-2610.
29. Wistuba II, Behrens C, Milchgrub S, t al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA. 1998;279:1554-1559.
30. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857-862.
31. Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer. 1994;70: 813-818.
32. Toguchida J, McGee TL, Paterson JC, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics. 1993;17: 535-543.
33. Wistuba II, Bryant D, Behrens C, et al. Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin Cancer Res. 1999;5:991-1000.
34. Fountain JW, Karayiorgou M, Ernstoff MS, et al. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA. 1992;89:10557-10561.
35. Holland EA, Beaton SC, Edwards BG, et al. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene. 1994;9: 1361-1365.
36. Isshiki K, Seng BA, Elder DE, et al. Chromosome 9 deletion in sporadic and familial melanomas in vivo. Oncogene. 1994;9:1649-1653.
37. Cannon-Albright LA, Goldgar DE, Neuhausen S, et al. Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics. 1994;23:265-268.
38. Cachia AR, Indsto JO, McLaren KM, et al. CDKN2A mutation and deletion status in thin and thick primary melanoma. Clin Cancer Res. 2000;6:3511-3515.
39. Herbst RA, Weiss J, Ehnis A, et al. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 1994;54:3111-3114.
40. Isshiki K, Elder DE, Guerry D, et al. Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer. 1993;8:178-184.
41. Florenes VA, Oyjord T, Holm R, et al. TP53 allele loss, mutations and expression in malignant melanoma. Br J Cancer. 1994;69:253-259.
42. Bastian BC, Olshen AB, LeBoit PE, et al. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163: 1765-1770.
43. Bartkova J, Lukas J, Guldberg P, et al. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 1996;56:5475-5483.
44. O'Connor DP, Kay EW, Leader M, et al. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol. 2001;54: 165-169.
45. Tomlinson IP, Gammack AJ, Stickland JE, et al. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers. Genes Chromosomes Cancer. 1993;7:169-172.
46. Tomlinson IP, Beck NE, Bodmer WF. Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. Eur J Cancer. 1996; 32A:1797-1802.
47. Alonso M, Hamelin R, Kim M, et al. Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. Cancer Res. 2001;61:2124-2128.
48. Perucho M. Microsatellite instability: the mutator that mutates the other mutator. Nat Med. 1996;2:630-631.